Osteopenia
Conditions
Interventions
Investigational Product Group:Instant Cornus officinalis powder
Sponsors
The First People's Hospital of Kunshan
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Aged 35-70 years, both males and females eligible; 2.Diagnosed with osteopenia by ultrasound examination; 3.Signed informed consent form;
Exclusion criteria
Exclusion criteria: 1.Diagnosed with osteoporosis; 2.Severe cardiac, hepatic, or renal insufficiency, malignant tumors, or mental disorders; 3.Known or suspected history of allergy to the investigational product or its excipients; 4.Currently using medications that may interfere with the results (e.g., bisphosphonates, denosumab, teriparatide, raloxifene, or other osteoporosis treatments); 5.Use of similar nutritional supplements within the recent 6 months and unable to discontinue; 6.Pregnant or breastfeeding women, or those planning to become pregnant during the trial period; 7.Considered by the investigator to have poor compliance, or any other condition deemed unsuitable for participation in this trial;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density; | — |
Secondary
| Measure | Time frame |
|---|---|
| Parathyroid hormone (PTH);Cystatin C;Estimated Glomerular Filtration Rate;Phosphorus;Total procollagen type I N-terminal propeptide (P1NP);Calcium;Creatinine;25-hydroxyvitamin D(25-(OH)D);C-terminal telopeptide of type I collagen (CTX); | — |
Countries
China
Contacts
Public ContactGuo Zhengli
The First People's Hospital of Kunshan
Outcome results
None listed